The UCLA Integrated Substance Abuse Programs was founded in 1999 to formally merge the expertise, resources, and activities of several organizations involved in substance abuse research and treatment in Southern California. Supported by dozens of prominent colleagues, M. Douglas Anglin, Ph.D., Walter Ling, M.D., and Richard Rawson, Ph.D., together formed a unified, multidisciplinary consortium of researchers and clinical professionals investigating substance abuse and its treatment. The resulting organization, directed by Dr. Ling, with Drs. Rawson and Grella as Associate Directors and Dr. Anglin as Senior Advisor, has brought to bear a uniquely coordinated, comprehensive approach to the study and treatment of substance abuse.
More than a decade of ISAP activities have yielded results that significantly advanced the knowledge base regarding substance use disorders, its consequences, and its treatment, with salient impacts on practice and policy at local, regional, national, and international levels.
ISAP is the organizational home of the Pacific Southwest Addiction Technology Transfer Center (Pacific Southwest ATTC, Region 9), one of 10 regional centers, four national focus areas, and a national office supported by SAMHSA’s Center for Substance Abuse Treatment. The Pacific Southwest ATTC, which covers Arizona, California, Hawaii, Nevada, American Samoa, Commonwealth of the Northern Mariana Islands, Federated States of Micronesia, Guam, Republic of the Marshall Islands, and Republic of Palau provides training, information, and collaborative promotion of empirically proven substance abuse treatment practices. The Pacific Southwest ATTC seeks to increase knowledge about and improve the delivery of effective treatments for substance use disorder treatment providers. More information on the Pacific Southwest ATTC’s major training activities is available at www.psattc.org.
We have the capability, through ISAP and the Pacific Southwest ATTC, to provide trainings on a variety of topics, including:
Substance Use Disorders 101
Ethics and Confidentiality
Administration and Coding of the Addiction Severity Index (ASI)
Dealing with Difficult Clients
Addiction: A Brain Disease
Pharmacology of Addiction
Methamphetamine Treatment (Epidemiology, Etiology, and Physiology; Evidence-Based Treatment Approaches)
Best Practices in Addiction Treatment
Process Improvement Strategies to Improve Client Engagement and Retention in Treatment
Co-Occurring Substance Use and Mental Health Disorders
Screening, Assessment, Brief Intervention, and Referral to Treatment
Motivational Incentives/Contingency Management
Health Care Reform
Primary Care and Behavioral Health Integration
Treatment for individuals with special needs (i.e., criminal justice, lesbian, gay, bisexual, and transgender populations, and children and adolescents)
Specialty information for HIV/AIDS Care Providers (Alcohol and HIV; Crack Cocaine and HIV; Prescription Opioids and HIV; Substance Abuse, HIV, and Youth)
Medication-Assisted Treatment (buprenorphine, methadone, naltrexone, etc.)
ISAP- and Pacific Southwest ATTC-sponsored trainings are listed on the Training Calendar, available on the Pacific Southwest ATTC website. For more information, please visit www.uclaisap.org or www.psattc.org. Please contact Charlotte Bullen by phone (310-267-5408) or by e-mail (email@example.com) if you would like to receive e-mail announcements of upcoming training events.